- ￥1788 - 17268
- abinScience
- France
- VK750041
- 2026年08月30日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
AJE 润色服务限时 8 折起，权威机构信任 15+ 年Cytoscape 教程来了！快速实现顶刊同款通路网络图五大应用案例：Mustang Q 膜层析应用全解析1 个小工具，一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
-20℃
- 保质期：
12 months
- 英文名：
Recombinant Border disease virus (BDV) Glycoprotein E2 Protein, C-Fc
- 供应商：
武汉益普生物科技有限公司
- 规格：
50μg/100μg/1mg
| 规格： | 50μg | 产品价格： | ￥1788.0 |
|---|---|---|---|
| 规格： | 100μg | 产品价格： | ￥2868.0 |
| 规格： | 1mg | 产品价格： | ￥17268.0 |
| 产品名称 | Recombinant Border disease virus (BDV) Glycoprotein E2 Protein, C-Fc |
| 货号 | VK750041 |
| 描述 | Recombinant Border disease virus (BDV) Glycoprotein E2 Protein, C-Fc ( VK750041 ) expressed in Mammalian Cells , spanning Gln1-Asp333 . Highlights Fc Fusion — Enhanced stability with Protein A/G purification compatibility. Mammalian Expression — Proper folding and native glycosylation. High Purity — >90% purity verified by SDS-PAGE. |
| 应用实验 | SDS-PAGE, WB, ELISA, Immunogen, Bioactivity testing in progress |
| 宿主/表达体系 | Mammalian Cells |
| 靶点 | Glycoprotein E2 |
| 基因号 | NP_777538.1 |
| 状态 | Lyophilized |
| 蛋白质长度 | Gln1-Asp333 |
| 分子量 | 66.01 kDa |
| 纯度 | >95% as determined by SDS-PAGE. |
| 储存温度 | -20℃ |
| 别名 | Glycoprotein E2 |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Characterization of the Dengue Virus Envelope Glycoprotein Expressed in Pichia pastoris
The full-length and truncated forms of recombinant envelope (E) glycoprotein from Dengue virus type 1, Singapore strain S275/90 were expressed in the yeast, Pichia pastoris , using a secretory vector. A truncated form of the E protein
Cloning, Expression, and Functional Analysis of Patient-Derived Hepatitis C Virus Glycoproteins
Hepatitis C virus (HC V) infection is a major cause of severe chronic liver disease including cirrhosis and hepatocellular carcinoma. HCV has been classified into six major genotypes that exhibit extensive genetic variability, particularly
RT-PCR for the Assessment of Genetically Heterogenous Populations of the Hepatitis C Virus
Since the discovery of the Hepatitis C Virus (HCV) in 1989 (1 ), known to that point as the infectious agent of Non-A Non-B hepatitis (2 ), there has been an intensive focus on understanding the underlying biology of its disease process
技术资料暂无技术资料 索取技术资料
